Bahamas vs Colombia: Access to anti-retroviral drugs, female
Bahamas
76.0%
in 2024
Colombia
77.0%
in 2023
Bahamas rank
64th
Colombia rank
63rd
Access to anti-retroviral drugs, female over time
- Bahamas
- Colombia
How they compare
Colombia currently reports 77.0% against 76.0% in Bahamas, a difference of 1.0%.
The two have swapped places 6 times across 24 shared years of data; in 2000 it was Colombia ahead.
Bahamas ranks 64th and Colombia ranks 63rd of 141 countries.
Across the 3 decades both report, Bahamas averaged higher in 2 and Colombia in 1.
Head to head by decade
| Decade | Bahamas | Colombia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 22.9% | 8.2% | 14.7% | Bahamas |
| 2010s | 58.5% | 52.0% | 6.5% | Bahamas |
| 2020s | 74.0% | 75.5% | 1.5% | Colombia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Bahamas or Colombia?
- Colombia, at 77.0% against 76.0% in Bahamas as of 2023.
- What is the difference in access to anti-retroviral drugs, female between Bahamas and Colombia?
- 1.0%, with Colombia ahead.
- How many years of comparable data are there for Bahamas and Colombia?
- 24 years are reported by both, from 2000 to 2023.
- How do Bahamas and Colombia rank globally for access to anti-retroviral drugs, female?
- Bahamas ranks 64th and Colombia ranks 63rd of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.